[1] Sumitran, H.S. (2008) Relevance of MICA and Other Non-HLA Antibodies in Clinical Transplantation. Current Opinion in Immunology, 20, 607-613. http://dx.doi.org/10.1016/j.coi.2008.07.005
[2] Opelz, G. (2005) Non-HLA-Transplantation Immunity Revealed by Lymphocytotoxic Antibodies. Lancet, 365, 1570-1576. http://dx.doi.org/10.1016/S0140-6736(05)66458-6
[3] Panigrahi, A., Gupta, N., Siddiqui, J.A., et al. (2007) Post Transplant Development of MICA and Anti-HLA Antibodies Is Associated with Acute Rejection Episodes and Renal Allograft Loss. Human Immunology, 68, 362-367.
http://dx.doi.org/10.1016/j.humimm.2007.01.006
[4] Bahram, S., Bresnahan, M., Geraghty, D.E. and Spies, T. (1994) A Second Lineage of Mammalian Major Histocompatibility Complex Class I Genes. The Proceedings of the National Academy of Sciences of the United States of America, 91, 6259-6263. http://dx.doi.org/10.1073/pnas.91.14.6259
[5] Petersdorf, E.W., Shuler, K.B., Longton, G.M., Spies, T. and Hansen, J.A. (1999) Population Study of Allelic Diversity in the Human MHC Class I-Related MIC-A Gene. Immunogenetics, 49, 605-612.
http://dx.doi.org/10.1007/s002510050655
[6] Zwirner, N.W., Marcos, C.Y., Mirbaha, F., Zou, Y. and Stastny, P. (2000) Identification of MICA as a New Polymorphic Alloantigen Recognized by Antibodies in Sera of Organ Transplant Recipients. Human Immunology, 61, 917-924.
http://dx.doi.org/10.1016/S0198-8859(00)00162-2
[7] Zwirner, N.W., Fernandez-Vina, M.A. and Stastny, P. (1998) MICA, a New Polymorphic HLA-Related Antigen, Is Expressed Mainly by Keratinocytes, Endothelial Cells, and Monocytes. Immunogenetics, 47, 139-148.
http://dx.doi.org/10.1007/s002510050339
[8] Clatworthy, M., Espeli, M., Torpey, N. and Smith, K. (2010) The Generation and Maintenance of Serum Alloantibody. Current Opinion in Immunology, 22, 669-681. http://dx.doi.org/10.1016/j.coi.2010.08.018
[9] Choy, M.K. and Phipps, M.E. (2010) MICA Polymorphism: Biology and Importance in Immunity and Disease. Trends in Molecular Medicine, 16, 97-106. http://dx.doi.org/10.1016/j.molmed.2010.01.002
[10] Sumitran, H.S., Wilczek, H.E., Holgersson, J. and Soderstrom, K. (2002) Identification of the Nonclassical HLA Molecules, Mica, as Targets for Humoral Immunity Associated with Irreversible Rejection of Kidney Allografts. Transplantation, 74, 268-277. http://dx.doi.org/10.1097/00007890-200207270-00019
[11] Li, L., Wadia, P., Chen, R., Kambham, N., Naesens, M., Sigdel, T.K., et al. (2009) Identifying Compartment-Specific Non-HLA Targets after Renal Transplantation by Integrating Transcriptome and “Antibodyome” Measures. Proceedings of the National Academy of Sciences of the United States of America, 106, 4148-4153.
http://dx.doi.org/10.1073/pnas.0900563106
[12] Dragun, D. and Hegner, B. (2009) Non-HLA Antibodies Post-Transplantation: Clinical Relevance and Treatment in Solid Organ Transplantation. Contributions to Nephrology, 162, 129-139. http://dx.doi.org/10.1159/000170845
[13] Mizutani, K., Terasaki, P., Rosen, A., Esquenazi, V., Miller, J., Shih, R.N.J., et al. (2005) Serial Ten-Year Follow-Up of HLA and MICA Antibody Production Prior to Kidney Graft Failure. American Journal of Transplantation, 5, 2265-2272. http://dx.doi.org/10.1111/j.1600-6143.2005.01016.x
[14] Ormonde, D.G., De-Boer, W.B., Kierath, A., Bell, R., Shilkin, K.B., House, A.K., et al. (1999) Banff Schema for Grading Liver Allograft Rejection: Utility in Clinical Practice. Liver Transplantation and Surgery, 5, 261-268.
http://dx.doi.org/10.1002/lt.500050418
[15] Solez, K., Axelsen, R.A., Benediktsson, H., Burdick, J.F., Cohen, A.H., Colvin, R.B., et al. (1993) International Standardization of Criteria for the Histologic Diagnosis of Renal Allograft Rejection: The Banff Working Classification of Kidney Transplant Pathology. Kidney International, 44, 411-421. http://dx.doi.org/10.1038/ki.1993.259
[16] Paramesh, A.S., Zhang, R., Baber, J., Yau, C.L., Slakey, D.P., Killackey, M.T., et al. (2010) The Effect of HLA Mismatch on Highly Sensitized Renal Allograft Recipients. Clinical Transplantation, 24, E247-E252.
http://dx.doi.org/10.1111/j.1399-0012.2010.01306.x
[17] Panigrahi, A., Deka, R., Bhowmik, D., Tiwari, S.C. and Mehra, N.K. (2004) Immunological Monitoring of Posttrans-plant Allograft Sensitization Following Living Related Donor Renal Transplantation. Transplantation Proceedings, 36, 1336-1339. http://dx.doi.org/10.1016/j.transproceed.2004.05.072
[18] Hourmant, M., Cesbron, G.A., Terasaki, P.I., Mizutani, K., Moreau, A., Meurette, A., et al. (2005) Frequency and Clinical Implications of the Development of Donor-Specific and Non-Donor-Specific HLA Antibodies after Kidney Transplantation. Journal of the American Society of Nephrology, 16, 2804-2812.
http://dx.doi.org/10.1681/ASN.2004121130
[19] Terasaki, P.I., Ozawa, M. and Castro, R. (2007) Four-Year Follow-Up of a Prospective Trial of HLA and MICA Antibodies on Kidney Graft Survival. American Journal of Transplantation, 7, 408-415.
http://dx.doi.org/10.1111/j.1600-6143.2006.01644.x
[20] Stastny, P., Zou, Y., Fan, Y., Qin, Z. and Lavingia, B. (2009) The Emerging Issue of MICA Antibodies: Antibodies to MICA and Other Antigens of Endothelial Cells. Contributions to Nephrology, 162, 99-106.
http://dx.doi.org/10.1159/000170842
[21] Kauke, T., Kaczmarek, I., Dick, A., Schmoeckel, M., Deutsch, M.A., Beiras-Fernandez, A., et al. (2009) Anti-MICA Antibodies Are Related to Adverse Outcome in Heart Transplant Recipients. Journal of Heart and Lung Transplantation, 28, 305-311. http://dx.doi.org/10.1016/j.healun.2009.01.003
[22] Fodil, N., Laloux, L., Wanner, V., Pellet, P., Hauptmann, G., Mizuki, N., et al. (1996) Allelic Repertoire of the Human MHC Class IMICA Gene. Immunogenetics, 44, 351-357. http://dx.doi.org/10.1007/BF02602779
[23] Hankey, K.G., Drachenberg, C.B., Papadimitriou, J.C., Klassen, D.K., Philosophe, B., Bartlett, S.T., et al. (2002) MIC Expression in Renal and Pancreatic Allografts. Transplantation, 73, 304-306.
http://dx.doi.org/10.1097/00007890-200201270-00029
[24] Zafar, M.N., Terasaki, P.I., Naqvi, S.A. and Rizvi, S.A. (2006) Non-HLA Antibodies after Rejection of HLA Identical Kidney Transplants. Clinical Transplants, 421-426.
[25] Zou, Y. and Stastny, P. (2009) The Role of Major Histocompatibility Complex Class I Chain-Related Gene A Antibodies in Organ Transplantation. Current Opinion in Organ Transplantation, 14, 414-418.
http://dx.doi.org/10.1097/MOT.0b013e32832d835e
[26] Kitcharoen, K., Witt, C.S., Romphruk, A.V., Christiansen, F.T. and Leelayuwat, C. (2006) MICA, MICB, and MHC Beta Block Matching in Bone Marrow Transplantation: Relevance to Transplantation Outcome. Human Immunology, 67, 238-246. http://dx.doi.org/10.1016/j.humimm.2006.02.012